Abstract: A liquid discharge head includes a liquid discharge substrate that has a discharge-orifice row, pressure generating elements, and pressure chambers. The liquid discharge head discharges a liquid in a block-by-block manner using sequential driving. The discharge-orifice row is disposed so as to incline at an angle ?=Arctan (d1/d2) relative to a direction extending orthogonal to the conveyance direction of the medium, in which d1 (?m) is a disposition spacing of the discharge orifices in the discharge-orifice row in the conveyance direction and d2 (?m) is a disposition spacing of the discharge orifices in the discharge-orifice row in the direction orthogonal to the conveyance direction. A partition wall is formed between adjacent pressure chambers so as to separate the adjacent pressure chambers from each other. The partition wall has a communicating portion that communicates the adjacent pressure chambers with each other.

Abstract: To provide a novel colitis ameliorating agent. A colitis ameliorating agent comprising a trans-astaxanthin derivative of formula (I), geometric isomers thereof, a mixture of the geometric isomers, an optical isomer thereof, or a salt thereof; (wherein m1, m2, n1, and n2 are each the same or different and mean an integer of 1 to 6).

Abstract: Pharmacological compositions containing a hydroxamic acid derivative selected from (2S)-2-((4-((4-((1S)-1,2-dihydroxyethyl)phenyl)ethynyl)benzoyl)(methyl)amino)-N-hydroxy-N?,2-dimethylmalonamide, (2S)-2-((4-((4-((1R)-1,2-dihydroxyethyl)phenyl)ethynyl)benzoyl)(methyl)amino)-N-hydroxy-N?,2-dimethylmalonamide, and (2S)—N-hydroxy-2-((4-((4-((1S)-1-hydroxy-2-methoxyethyl)phenyl)ethynyl)benzoyl)(methyl)amino)-N?,2-dimethylmalonamide, or a salt of said derivatives, and an antibiotic substance are useful in the treatment of gram-negative bacterial infections.

Abstract: Pharmacological compositions containing a hydroxamic acid derivative selected from (2S)-2-((4-((4-((1S)-1,2-dihydroxyethyl)phenyl)ethynyl)benzoyl)(methyl)amino)-N-hydroxy-N?,2-dimethylmalonamide, (2S)-2-((4-((4-((1R)-1,2-dihydroxyethyl)phenyl)ethynyl)benzoyl)(methyl)amino)-N-hydroxy-N?,2-dimethylmalonamide, and (2S)—N-hydroxy-2-((4-((4-((1S)-1-hydroxy-2-methoxyethyl)phenyl)ethynyl)benzoyl)(methyl)amino)-N?,2-dimethylmalonamide, or a salt of said derivatives, and an antibiotic substance are useful in the treatment of gram-negative bacterial infections.